Finding better ways to treat cancer
Bolt is committed to generating breakthroughs for patients in need of new treatment options while maintaining the best quality of life possible. Despite the power of current cancer immunotherapies, we know that people living with cancer still face significant treatment challenges. We aim to make a difference for patients in the long term, utilizing an approach that works with your body, not against it.
Bolt Biotherapeutics Clinical Trials
If you are interested in participating in a clinical trial for one of our investigational medicines below, we encourage you to speak with your physician about the possibility of enrolling.
| Program | Phase | Indication |
|---|---|---|
| BDC-3042 | 1 |
|
| Program | Phase | Indication |
|---|---|---|
| BDC-3042 | 1 |
|
Visit clinicaltrials.gov to learn more about study participation including eligibility, risks and benefits of participation, the informed consent process, and questions to ask when considering study participation.
If you have questions about our clinical trials, please email us at clinicaltrials@boltbio.com.
Expanded Access Policy
At this time, participation in clinical trials is the only way to gain access to our investigational medicines. Bolt Biotherapeutics will review and update its policy on offering patients Expanded Access from time to time as additional clinical data becomes available.